What Is The Forecast Valuation Of The Global Oncology Ablation Market Projected To Reach $2.33 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Big Is The Oncology Ablation Market Today And What Is Its Future Size?
A swift expansion has been witnessed in recent years in the oncology ablation market size. The market, which is set to rise from $1.3 billion in 2024 to $1.45 billion in 2025, boasts a compound annual growth rate (CAGR) of 12.1%. Factors contributing to the growth trend during the historic period include a surge in cancer cases, growing inclination towards minimally invasive ablation procedures, amplified healthcare expenditure, approvals for novel ablation devices and technologies, enhancements in cancer screening initiatives, and an increase in the ageing population.
Anticipated to witness a swift expansion in the coming years, the oncology ablation market will surge to $2.33 billion by 2029, recording a compound annual growth rate (CAGR) of 12.5%. This progression in the projected timeframe is influenced by continuous developments in ablation science, the spreading acceptance of ablation methodologies in developing countries, the evolution of precision and personalized medication, soaring government funding and support for novel cancer treatments and research, a burgeoning request for outpatient processes, as well as increased awareness both among the public and professionals. The forthcoming projection period will see trends such as the incorporation of artificial intelligence (AI), imaging technology advancements, robot-facilitated ablation, debut of sophisticated ablation apparatus that demonstrates better efficacy, safety, and ease of use, and the application of telehealth for care before and after ablation, permitting remote observation and check-ups.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp
Which Key Factors Are Fueling Growth In The Oncology Ablation Market?
The escalation in cancer diagnosis is predicted to drive the expansion of the oncology ablation market in the future. The term ‘cancer diagnosis’ involves the identification and verification of cancer presence through medical examinations, imaging studies, and pathological scrutiny of tissue samples. Factors vis-a-vis soaring cancer diagnoses include an aging populace, amplified screening programs, elevated awareness bringing to light early detection, and environmental triggers. Oncology ablation is employed to treat tumors identified during cancer diagnosis, providing minimally invasive alternatives to annihilate tumors and enhance patient results. For instance, the National Cancer Institute reported in May 2024, that the US is likely to see roughly 2,001,140 new cancer cases in 2024, with prostate, lung, and colorectal cancers constituting about 48% of all male diagnoses. Predictions for 2040 show an escalated annual incidence of cancer cases to 29.9 million, indicating a notable future upturn in cancer occurrence. Moreover, the American Cancer Society indicated in June 2022, that about 1.9 million new cancer cases were identified in the USA in 2022. Consequently, the boost in cancer diagnoses is expected to fuel the oncology ablation market.
How Is The Oncology Ablation Market Segmented Across Key Categories?
The oncology ablationmarket covered in this report is segmented –
1) By Technology: Radiofrequency Ablation; Microwave Ablation; Cryoablation; Irreversible Electroporation Ablation
2) By Treatment: Surgical Ablation; Laparoscopic Ablation; Percutaneous Ablation
3) By Application: Kidney Cancer; Liver Cancer; Breast Cancer; Lung Cancer; Prostate Cancer
Subsegments:
1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation; Bipolar Radiofrequency Ablation
2) By Microwave Ablation: Single-Probe Microwave Ablation; Multi-Probe Microwave Ablation
3) By Cryoablation: Cryo-Needle Ablation; Cryo-Generator System Ablation
4) By Irreversible Electroporation Ablation: Transurethral IRE; Transperineal IRE; Percutaneous IRE
What Key Trends Are Driving Growth In The Oncology Ablation Market?
The leading firms in the oncology ablation market are evolving by creating groundbreaking products such as superior ablation systems with high precision, integrated imaging technologies for real-time direction, and augmented safety features. The term ‘Superior ablation systems with high precision’ denotes medical instruments utilizing cutting-edge techniques to accurately identify and annihilate abnormal tissue, mainly tumors while reducing injury to nearby healthy tissue. For example, Medtronic Plc, a medical equipment manufacturing firm headquartered in Ireland, received clearance from the US Food and Drug Administration for their new OsteoCool 2.0 bone tumor ablation system in March 2024. This system, designed to address painful bone metastases and benign tumors like osteoid osteoma, boasts major improvements, including the capability to employ four internal cooling probes at the same time. This feature enables the ablation of two vertebral bodies simultaneously or the creation of larger ablation zones in non-spinal applications.
Who Are The Leading Companies Driving The Oncology Ablation Market?
Major companies operating in the oncology ablation market are Medtronic plc, Siemens Healthineers AG, Becton Dickinson and Company, Koninklijke Philips N.V., Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Varian Medical Systems Inc, PENTAX Medical, Elekta AB, Merit Medical Systems Inc, AtriCure Inc, AngioDynamics Inc., EDAP TMS S.A., Monteris Medical Inc., Misonix Inc., MedWaves Inc., BSD Medical Corporation, Cardiva Medical Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report
Which Region Dominates The Oncology Ablation Market Today?
North America was the largest region in the oncology ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=18415&type=smp
Browse Through More Reports Similar to the Global Oncology Ablation Market 2025, By The Business Research Company
Oncology Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report
Immuno Oncology Drug Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report
Oncology Molecular Diagnostics Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
